Subsequent immunohistochemical analysis of specimens representing OSCC development revealed that fascin levels were already significantly upregulated in mild dysplasias, keeping higher levels throughout oral cancer progression, whereas plectin upregulation was detected only in cancer areas. The gene discussed is FSCN1; the disease is cancer.